These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1186482)

  • 1. [Clinical experience with Cerebrolysin in geriatrics].
    Krauss W
    Med Welt; 1975 Oct; 26(42):1937-9. PubMed ID: 1186482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of apoplectic attack using a higher single dose of Cerebrolysin].
    Sütterlin F
    Med Welt; 1977 Aug; 28(30-31):1289-90. PubMed ID: 895476
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapeutical effect of a brain-hydrolisate from a point of view of the clinic and the animal experimentations (author's transl)].
    Sommer H; Harrer G
    Folia Clin Int (Barc); 1973 Sep; 23(9):598-615. PubMed ID: 4805352
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment with a brain tissue hydrolysate. Clinical observations and results of experimental studies].
    Harrer G; Sommer H
    Neurol Neurochir Pol; 1974; 8(5):737-43. PubMed ID: 4215047
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy with the cerebral hydrolysate cerebrolysin. A practice report].
    Bayer E
    Med Welt; 1980 Apr; 31(17):636, 637. PubMed ID: 7191468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of cerebrolysin and ATP in treating infantile cerebral paralysis].
    Gershman RN; Vasilenko MA
    Pediatr Akus Ginekol; 1975; (1):22-3. PubMed ID: 1228606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies on the effect of a phospholipid complex from cattle brain in cerebral circulation disorders].
    Cloetens W; Cretallaz JC; Depaepe A; Bertholet G
    Med Welt; 1970 Mar; 12():510-5. PubMed ID: 5462778
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic influence of cerebrolysin on the long-term stress barrier after an accident].
    Wanderka H
    Z Allgemeinmed; 1975 Sep; (26):1161-6. PubMed ID: 1226796
    [No Abstract]   [Full Text] [Related]  

  • 9. [Do brain hydrolysates potentiate the action of tricyclic antidepressive agents?].
    Böhme K
    MMW Munch Med Wochenschr; 1975 Oct; 117(40):1311-2. PubMed ID: 810683
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of cerebrolysin(r) on the resistance of rats to anoxia.
    Trojanová M; Karásek F; Pruzková V; Mourek J
    Physiol Bohemoslov; 1976; 25(4):319-23. PubMed ID: 135987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with Ruleran, a new geriatric preparation].
    Puller G
    Landarzt; 1968 Nov; 44(31):1541-3. PubMed ID: 5730427
    [No Abstract]   [Full Text] [Related]  

  • 12. [Agents to improve cerebrovascular circulation and cerebral metabolism--cellryl].
    Hasegawa T
    Nihon Rinsho; 1985 Feb; 43(2):392-6. PubMed ID: 3889413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Crelizin; experimental and clinical data].
    Dinu A; Cristescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1976; 21(3):241-4. PubMed ID: 1088202
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimental studies of the activity of a cellular extract (TRF). V. Changes of the EEG].
    Sepe O; De Luca R; Stella L; Del Giudice E; Federico P; Portone N
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1873-5. PubMed ID: 5735737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiradiation effectiveness of amino acid mixtures of various compositions].
    Lapteva TA; Bezkrovnaia LA
    Radiobiologiia; 1989; 29(3):359-62. PubMed ID: 2762526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cerebrolysin in patients with cerebral arteriosclerosis].
    Zhovnir IK; Brozhik NS; Krotiuk LN
    Vrach Delo; 1973 Nov; 11():109-11. PubMed ID: 4786906
    [No Abstract]   [Full Text] [Related]  

  • 17. [Piribedil, dopaminergic agonist and the cerebral neurovascular syndrom of the aging man (author's transl)].
    Babeau P; Pras P; Serizet A
    Sem Hop; 1980 Jan 18-25; 56(3-4):188-92. PubMed ID: 6244655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the use of vitamin E nicotinate in cerebral diseases caused by debilitation].
    Poggi E; Sforzini D; Tosarelli L
    Sist Nerv; 1971; 23(7):126-32. PubMed ID: 5005842
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebral deficiency symptoms. Influencing cerebral metabolism in cerebral deficiency symptoms using a brain hydrolysate].
    Hanák T
    ZFA (Stuttgart); 1978 Jun; 54(18):972-6. PubMed ID: 676440
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of cytochrome C in neurosurgery (apropos of 60 cases)].
    Boulanger JP; Dechaume JP
    J Med Lyon; 1969 Feb; 50(158):195-205. PubMed ID: 5782370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.